In vivo tumor growth assay All animal studies were conducted acco

In vivo tumor growth assay All animal studies were conducted according to protocols approved by MD Anderson Cancer Center’s Institutional Animal Care and Use Committee. Jurkat cells (5 × 106 per injection) were re-suspended in sterile PBS and subcutaneously injected into the right flank of 5-week-old CB17/SCID mice (Harlan Laboratories, Indianapolis, IN). When xenograft tumors reached 100 mm3, the mice were given a single intratumoral injection of SC79 concentration peptides (33.9 mg/kg): S20-3, TCR, or vehicle; 4 mice each. The mice were killed 8 days after injection, and

the tumor tissue was harvested. Tumor width (W) and length (L) were measured by calipers, and size was calculated using the

formula www.selleckchem.com/products/JNJ-26481585.html W2× L/2. The tumoricidal activity was evaluated by comparison of tumor size among groups. Statistical analysis The 2-tailed Student’s t test was used to estimate the statistical significance of the differences between results from triplicate samples or experiments, and the results are expressed as mean values ± standard deviations or standard errors, respectively. The level of significance was set at P < 0.05. Results S20-3 peptide induces cell death of BJABK1 cells Our previous studies demonstrated that wild-type ACY-738 mw K1, but not a truncated K1 with the Ig-like domain deleted, binds to Fas and prevents Fas activation by FasL or by an agonistic Fas antibody [8, 10]. To further elucidate K1-mediated regulation of Fas, we designed peptides derived from the Ig-like domain of K1 (Table 1), targeting the K1 binding site on the Fas receptor. Table 1 Protein sequence of the Ig-like domain of human herpesvirus 8 K1 protein and derived peptides K1 Ig-domain   HSLWITWYPQPVLQTLCGQPSNTVTCGQYVTLYCSTSGNYVTVW K1 peptides     20 amino acids S20-1 HSLWITWYPQPVLQTLCGQP (84–103) S20-2 PVLQTLCGQPSNTVTCGQYV

(94–113)   S20-3 SNTVTCGQYVTLYCSTSGNYV (104–124) 10 amino acids S10-1 SNTVTCGQYV (104–113)   S10-2 TVTCGQYVTL (106–115) 8 amino acids S8-1 TVTCGQYV (106–113)   S8-2 VTLYCSTS (113–120) We first investigated whether K1 peptides GPX6 could sensitize the Burkitt’s lymphoma cell line BJAB stably expressing K1 (BJABK1) to Fas-mediated apoptosis. Cells were treated with 100 μM peptide in combination with 200 ng/mL of FasL for 24 hours, followed by analysis of apoptosis by flow cytometry. The combination of S20-3 and S10-1 peptides with FasL showed a significant (2.2- and 2.5-fold, respectively) increase in cell death compared with FasL alone (Figure 1A). No significant differences in apoptosis rates were seen with FasL in combination with other K1-derived peptides shown in Table 1 (20–1, 20–2, S10-2, S8-1, S8-2). Figure 1 A human herpesvirus 8 K1 peptide induces dose-dependent cell death and activates caspase cascade in BJABK1 cells.

Comments are closed.